Priority Review for Pfizer's meningitis B vaccine

FDA accepted and granted Priority Review to a BLA from Pfizer Inc. (NYSE:PFE) for recombinant LP2086 ( rLP2086) to prevent invasive meningococcal disease caused by Neisseria meningitides serogroup B ...